First Patient Recruited to Cohort 3 of ACCENT Trial in Pancreatic Cancer
Posted: 19 April 2023 Amplia Therapeutics Limited is pleased to advise that dosing of the first patient in Cohort 3 of the Company’s ongoing Phase 1b/2a ACCENT clinical trial of FAK inhibitor AMP945 in pancreatic cancer has begun.…
Two New Deoxymab Patents Granted in the USA
Posted: 19 April 2023 Patrys Limited, a therapeutic antibody development company, is pleased to announce that the US Patent and Trademark Organisation has granted two patents that provide further intellectual property protection for Patrys’ deoxymab antibody technology until…
Ginkgo Bioworks and WARF Announce Partnership to Discover Next Generation GD2 CAR T-Cell Therapies
Posted: 19 April 2023 The Wisconsin Alumni Research Foundation (WARF), which has a mission of supporting research at the University of Wisconsin-Madison, and Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, today announced…
Ginkgo Bioworks and Syngenta Seeds Announce Collaboration to Develop New Traits for the Next Generation of Seed Technology
Posted: 19 April 2023 Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, and Syngenta Seeds, one of the world’s leading agricultural technology companies, announced a research partnership focused on screening a targeted genetic…
Former U.S. Secretary of Veterans Affairs Dr David Shulkin assumes advisory role with 4DMedical
Posted: 19 April 2023 Respiratory imaging technology disruptor 4DMedical Limited announces that Dr David Shulkin, MD, has assumed an advisory role within the company. As an accomplished and prominent health care system leader, physician, academic, and industry entrepreneur,…
Atmo Biosciences strengthens US focus with new board appointment and establishment of San Diego office
Posted: 17 April 2023 Atmo Biosciences, a company commercialising the world’s first ingestible gas-sensing capsule that provides insights into gut health and microbiome function, is strengthening its US focus with the appointment of experienced medical device executive Chris…
Cynata Receives Ethics Committee Approval for Proposed aGvHD Phase 2 Clinical Trial
Posted: 12 April 2023 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, has today announced that it has received approval from the Australian Human Research Ethics Committee (HREC) to commence the proposed Phase 2 clinical…
Desperate pain patients spending thousands on unproven stem cell therapies
Posted: 12 April 2023 y Professor David Hunter, Florance and Cope Chair of Rheumatology and Professor of Medicine, University of Sydney and Royal North Shore Hospital Australians living with arthritis pain are parting with thousands of dollars, sometimes tens…
COVID VACCINE INDUCES ROBUST T CELL RESPONSES IN BLOOD CANCER PATIENTS
Posted: 12 April 2023 Researchers found that, despite being heavily immunocompromised, haematology patients generate strong cellular immune responses against SARS-CoV-2 after vaccination, on par with that of healthy individuals. Published today in Cell Reports Medicine, the research team, led…
Dose Escalation Approved in ACCENT Clinical Trial of AMP945
Posted: 12 April 2023 Amplia Therapeutics Limited is pleased to advise that following a review of safety data collected to date, the ACCENT clinical trial’s Safety Review Committee has approved dose escalation of AMP945 and recruitment of a…
Iron link offers new treatment hope for incurable blood cancer
Posted: 12 April 2023 A landmark discovery linking iron regulation to a rare blood cancer has led to clinical trials of a potential new treatment for patients with the incurable disease. The study focused on polycythemia vera (PV),…
Resistance-fighting antimalarial drug candidate enters the clinic
Posted: 12 April 2023 A new antimalarial drug candidate, discovered through a longstanding collaboration between WEHI and global biopharmaceutical company MSD has entered Phase 1 clinical testing in healthy participants. The candidate inhibits two essential enzymes required for…
